ConCallIQ
Go Pro

HUL Management Guidance Tracker

38 forward-looking guidance items tracked across 10 quarters.

Revenue

Q1 FY24Price growth to be near flat or marginally negative in next 2 quartersActive

If commodities remain at current levels, HUL expects price growth to be near flat or marginally negative, with growth fully led by volume.

Q2 FY24Price growth to be marginally negative if commodities stayActive

Management expects price growth to turn marginally negative in the near term if current commodity prices hold.

Q1 FY25Near-zero pricing in short term, low single-digit positive by end of FY25Active

Excluding one-off credit in Q2 FY24 base, intrinsic price growth expected near zero in short term, turning low single-digit positive by year-end.

Q2 FY25Low single-digit price growth expected in near termActive

Management expects low single-digit price growth in the coming quarters due to commodity inflation, while maintaining competitive price-value equation.

Q3 FY25Low single-digit price growth expectedActive

If commodity prices remain at current levels, HUL expects low single-digit price growth in the near term.

Q4 FY25Price growth expected in low single-digit rangeActive

If commodities remain at current levels, management expects price growth to be in low single-digit range for the near term.

Q1 FY26Low single-digit price growth if commodities stay in current rangeActive

If commodity prices remain within the current range, management anticipates low single-digit price growth.

Q2 FY26Low single-digit price growth expectedActive

If commodity prices remain at current levels, management expects low single-digit price growth going forward.

Q3 FY26FY27 revenue growth better than FY26Tracked

Management expects FY27 top-line growth to exceed FY26, driven by improving macros and internal actions.

Q3 FY26Low single-digit price increases expected over FY27Tracked

Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.

Q4 FY26Price increases of 2-5% already takenActive

Calibrated price increases of 2-5% implemented across home care and personal care to offset input cost inflation.

Growth

Q1 FY24Volume growth momentum to be sustainedActive

Management expects to sustain volume growth momentum despite transition, supported by price reductions and A&P investments.

Q2 FY24Volume recovery expected to be gradualActive

Management expects volume recovery to continue gradually, supported by moderating inflation and festive season.

Q1 FY25Market share breadth to reach 60% by end of calendar yearTracked

MAT business winning metric expected to return to 60% levels by end of calendar year, with last 3-month metric already at ~55%.

Q3 FY25Demand moderation to continue in near termActive

Management expects current subdued demand trends to persist in the near term, with gradual rural recovery and urban moderation.

Q4 FY25First half of FY26 to be better than second half of FY25Active

Management expects growth trends to gradually improve in H1 FY26 due to improving macro conditions and internal portfolio transformation actions.

Q1 FY26First half FY26 better than second half FY25Active

Growth guidance unchanged: H1 FY26 expected to be better than H2 FY25, with gradual recovery sustained.

Q2 FY26H2 growth better than H1Active

Management expects second half of FY26 to deliver better growth than first half, driven by improving macros and internal initiatives.

Q3 FY26H2 FY26 better than H1 FY26Active

Second half of FY26 is expected to show stronger growth than the first half, with Q3 as a normalized base.

Q4 FY26FY27 to be better than FY26Tracked

Management expects FY27 performance to exceed FY26, driven by portfolio transformation and execution improvements.

Margins

Q1 FY24Gross margin to be rebuilt and invested in A&PActive

Focus on rebuilding gross margins and investing competitively behind A&P; EBITDA margin will be an outcome.

Q2 FY24EBITDA margin to be maintained in a healthy rangeActive

Management aims to keep EBITDA margin in a healthy range while investing in brands and capabilities.

Q1 FY25EBITDA margins to be maintained at current levels in short termActive

Management expects to maintain current EBITDA margin levels (~23.8%) in the near term, with modest expansion in medium term.

Q1 FY25Modest margin expansion in medium term via mix and operating leverageTracked

Medium-term margin expansion driven by premiumization (300 bps improvement in premium mix over 3 years) and operating leverage from volume growth.

Q2 FY25EBITDA margin to be maintained at current healthy levelsActive

Management aims to keep EBITDA margin at current ~23.8% levels, with some basis points fluctuation, through productivity savings and calibrated pricing.

Q3 FY25EBITDA margin at lower end of 23-24% rangeActive

Management expects EBITDA margin to be at the lower end of the 23-24% band in the near term due to inflationary material prices.

Q4 FY25EBITDA margin guidance of 22%-23% for next 2-3 quartersActive

Management expects EBITDA margin to be in the 22%-23% range for the next 2-3 quarters as they step up investments behind growth, before returning to modest expansion.

Q4 FY25Gross margin expected to moderate furtherActive

Gross margin is expected to moderate due to commodity inflation and continued commitment to provide the right price-value equation to consumers.

Q1 FY26EBITDA margin guidance of 22%-23% for near termActive

Management expects EBITDA margin to remain in the 22%-23% range for the next few quarters, with sequential gross margin improvement reinvested into the business.

Q2 FY26EBITDA margin guidance 22%-23%Active

Near-to-mid-term EBITDA margin guidance remains 22%-23%, with ice cream demerger adding 50-60 bps to reported margin from Q3.

Q3 FY26EBITDA margin to stay in 22-23% rangeActive

Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized.

Q4 FY26Medium-term EBITDA margin guidance 22.5-23.5%Tracked

Margin guidance maintained at 22.5-23.5% for the medium term, with flexibility to operate at lower end if cost pressures persist.

Other

Capex